Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclo-Z in Type 2 Diabetes
NCT00878605Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Apr 2010
- Primary completion
- Jun 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclo(histidyl-proline) + zinc in type 2 diabetes mellitus (T2DM), sponsored by VA Office of Research & Development. Started Apr 2010; status: terminated.
02
Drugs
cyclo(histidyl-proline) + zinc
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00878605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878605.